@article{3141539,
    title = "The Androgen Excess and PCOS Society criteria for the polycystic ovary
syndrome: the complete task force report",
    author = "Azziz, Ricardo and Carmina, Enrico and Dewailly, Didier and and Diamanti-Kandarakis, Evanthia and Escobar-Morreale, Hector F. and and Futterweit, Walter and Janssen, Onno E. and Legro, Richard S. and and Norman, Robert J. and Taylor, Ann E. and Witchel, Selina F. and Task and Force Phenotype Polycystic Ov",
    journal = "International Journal of Fertility and Sterility",
    year = "2009",
    volume = "91",
    number = "2",
    pages = "456-488",
    publisher = "EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC",
    doi = "10.1016/j.fertnstert.2008.06.035",
    keywords = "Polycystic ovary syndrome; hirsutism; menstrual dysfunction; phenotype;
criteria",
    abstract = "Objective: To review all available data and recommend a definition for
polycystic ovary syndrome (PCOS) based on published peer-reviewed data,
whether already in use or not, to guide clinical diagnosis and future
research.
Design: Literature review and expert consensus.
Setting: Professional society.
Patients: None.
Intervention(s): None.
Main Outcome Measure(s): A systematic review of the published
peer-reviewed medical literature, by querying MEDLINE databases, to
identify studies evaluating the epidemiology or phenotypic aspects of
PCOS.
Result(s): The Task Force drafted the initial report, following a
consensus process via electronic communication, which was then reviewed
and critiqued by the Androgen Excess and PCOS (AE-PCOS) Society AE-PCOS
Board of Directors. No section was finalized until all members were
satisfied with the contents, and minority opinions noted. Statements
were not included that were not supported by peer-reviewed evidence.
Conclusion(s): Based on the available data, it is the view of the
AE-PCOS Society Task Force that PCOS should be defined by the presence
of hyperandrogenism (clinical and/or biochemical), ovarian dysfunction
(oligo-anovulation and/or polycystic ovaries), and the exclusion of
related disorders. However, a minority considered the possibility that
there may be forms of PCOS without overt evidence of hyperandrogenism,
but recognized that more data are required before validating this
supposition. Finally, the Task Force recognized and fully expects that
the definition of this syndrome will evolve over time to incorporate new
research findings. (Fertil Steril (R) 2009;91:456-88. (C)2009 by
American Society for Reproductive Medicine.)"
}